The aim of the current study is to explore the stability of verbal memory functioning in a single institution cohort of children with epilepsy (CWE) over time and to identify seizure-related variables that predict improvement, decline, and stagnation. Retrospective chart review was conducted for 39 epilepsy patients (ages 5-19 years) seen for repeat neuropsychological evaluations. Twenty of these patients had epilepsy surgery between evaluations and 19 did not. Memory functioning outcomes included standardized scores from verbal list learning tasks. Findings revealed cross-sectional associations between verbal memory performance with age of seizure onset, overall IQ, and working memory. In particular, earlier age of seizure onset was associated with worse memory performance while higher IQ and working memory were associated with stronger memory performance, but most findings were not significant after Bonferroni correction for multiple comparisons. While approximately 50% of participants demonstrated stable performance across various verbal learning domains, approximately 10-20% demonstrated clinically meaningful decline and 28-38% demonstrated clinically meaningful improvement on at least one memory condition. Direct comparison of surgical vs. non-surgical groups revealed few differences although surgical patients were more likely to demonstrate stable immediate memory performance. These findings underscore the clinical utility of repeat neuropsychological evaluation and need for additional research on predictors of longitudinal memory functioning in patients with epilepsy.
Objective We investigated the clinical utility of the Wide Range Assessment of Memory and Learning, Third Edition (WRAML3), for use with a pediatric traumatic brain injury (TBI) population. Method This study is a cross-sectional cohort design comparing performance of youth (ages 5–17) with a history of TBI on the WRAML3 with healthy controls. Twenty-nine patients that had been hospitalized for TBI in the previous 6–34 months completed the WRAML3 as well as 29 matched healthy controls. Results No significant differences were detected between the overall TBI and healthy control groups. When comparing patients with a history of complicated mild TBI vs. those with a moderate to severe TBI, significant differences were found on the Design Learning subtest, Design Learning Recognition subtest, and on the Visual Immediate Memory Index. When comparing all three groups simultaneously, significant differences between groups were found on the Design Learning subtest and Design Learning Recognition subtest, such that the moderate to severe TBI group performed more poorly than control and complicated mild TBI groups. Children injured at an earlier age had poorer outcomes. Conclusions Memory deficits should not be expected after complicated mild TBI, but may be present in youth on the more severe end of the spectrum. Though findings were limited, the WRAML3 may be a useful tool in the assessment of memory functioning and neurocognitive recovery among pediatric patients that have experienced a TBI.
Individuals with Turner syndrome (TS) are known to be at increased risk for neurodevelopmental disorders (NDD) and mental health (MH) conditions, but data from large, population-based pediatric samples remain limited. We examined the prevalence of NDD and MH diagnoses among youth with TS (N = 2,145) compared to matched female controls (N = 8,580) across six U.S. pediatric health systems. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using generalized estimating equations. Youth with TS had significantly higher odds of an NDD diagnosis (24.2% vs. 11.9%; OR 2.37, 95% CI 2.11–2.67), particularly for speech-language, motor, learning, and attentional disorders. Increased odds were also observed for autism spectrum disorder (ASD) and intellectual developmental disorder (IDD), though these remained relatively uncommon. In contrast, MH diagnoses, such as anxiety and mood disorders, were not more prevalent in TS compared to controls (17.3% vs. 18.5%; OR 0.92, 95% CI 0.81–1.05). These findings support the need for proactive neurodevelopmental screening in TS and raise important questions about the recognition and documentation of MH conditions in this population. Additional research is warranted to understand whether MH symptoms are underdiagnosed in youth with TS or emerge later in development.